In NPC, this occurs via GL’s disruption of the critical HMGB1-Ku70 interaction, while in colorectal cancer, it inhibits HMGB1 to promote DNA fragmentation and apoptosis [37,38]. Here, XRCC6 is linked to nasopharyngeal carcinoma.